Quadient annonce la nomination d'une nouvelle Directrice Marketing, Petra Wolf
January 02, 2024 09:00 ET
|
QUADIENT
Quadient (Euronext Paris : QDT), un leader des solutions d’entreprise visant à faire de chaque interaction client – via un canal physique ou digital – une expérience riche et personnalisée, annonce la...
Quadient Announces Appointment of New Chief Marketing Officer, Petra Wolf
January 02, 2024 09:00 ET
|
QUADIENT
Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, today announced the appointment of Petra Wolf as new Chief...
Future Electronics Announces New Executive Team
February 08, 2023 07:46 ET
|
Future Electronics
MONTREAL, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Future Electronics today announced the further strengthening of its global executive team. Omar Baig, in addition to holding the positions of President...
Capgemini reinforces its focus on global industries and sustainability services with top leadership appointments
January 10, 2023 02:30 ET
|
Capgemini SE
Press Relations:Sam ConnattyTel.: +44 370 904 3601Email: sam.connatty@capgemini.com Capgemini reinforces its focus on global industries and sustainability services with top leadership appointments ...
Capgemini renforce son approche sectorielle et ses services en matière de développement durable avec l’annonce de deux nominations
January 10, 2023 02:30 ET
|
Capgemini SE
Press Relations:Victoire GRUXTel.: +33 6 04 52 16 55Email : victoire.grux@capgemini.com Capgemini renforce son approche sectorielle et ses services en matière de développement durable avec l’annonce...
ObsEva Announces Management Change
July 29, 2022 01:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 29, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel...
ObsEva Announces Corporate Updates
July 27, 2022 00:55 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel...
ObsEva Announces Appointment of Dr. Brandi Howard as Chief Clinical Officer
May 02, 2022 07:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 2, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
ObsEva Announces Appointment of Dr. Brandi Howard as Chief Clinical Officer
May 02, 2022 01:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 2, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
September 30, 2021 01:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – September 30, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and...